Does the sars-cov-2 spike protein receptor binding domain interact effectively with the dpp4 (Cd26) receptor? A molecular docking study

ACE2 has been established as the main receptor for SARS-CoV-2. Since other human coronaviruses are known to use co-receptors for viral cell entry, it has been suggested that DPP4 (CD26) could be a potential additional binding target or co-receptor, supported by early molecular docking simulation stu...

Full description

Bibliographic Details
Main Authors: Cameron, Kirsten, Rozano, Lina, Falasca, Marco, Mancera, Ricardo
Format: Journal Article
Language:English
Published: MDPI 2021
Subjects:
Online Access:http://hdl.handle.net/20.500.11937/86472
_version_ 1848764831880970240
author Cameron, Kirsten
Rozano, Lina
Falasca, Marco
Mancera, Ricardo
author_facet Cameron, Kirsten
Rozano, Lina
Falasca, Marco
Mancera, Ricardo
author_sort Cameron, Kirsten
building Curtin Institutional Repository
collection Online Access
description ACE2 has been established as the main receptor for SARS-CoV-2. Since other human coronaviruses are known to use co-receptors for viral cell entry, it has been suggested that DPP4 (CD26) could be a potential additional binding target or co-receptor, supported by early molecular docking simulation studies. However, recent biophysical studies have shown this interaction to be very weak. We have conducted detailed molecular docking simulations to predict the potential binding interactions between the receptor binding domain (RBD) of the spike protein of SARS-CoV-2 and DPP4 and compare them with the interactions observed in the experimentally determined structure of the complex of MERS-CoV with DPP4. Whilst the overall binding mode of the RBD of SARS-CoV-2 to DPP4 is predicted to be similar to that observed in the MERS-CoV-DPP4 complex, including a number of equivalent interactions, important differences in the amino acid sequences of SARS-CoV-2 and MERS-CoV result in substantially weakened interactions with DPP4. This is shown to arise from differences in the predicted proximity, nature and secondary structure at the binding interface on the RBD of SARS-CoV-2. These findings do not support DPP4 being a significant receptor for SARS-CoV-2.
first_indexed 2025-11-14T11:25:37Z
format Journal Article
id curtin-20.500.11937-86472
institution Curtin University Malaysia
institution_category Local University
language English
last_indexed 2025-11-14T11:25:37Z
publishDate 2021
publisher MDPI
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-864722021-11-26T03:12:35Z Does the sars-cov-2 spike protein receptor binding domain interact effectively with the dpp4 (Cd26) receptor? A molecular docking study Cameron, Kirsten Rozano, Lina Falasca, Marco Mancera, Ricardo Science & Technology Life Sciences & Biomedicine Physical Sciences Biochemistry & Molecular Biology Chemistry, Multidisciplinary Chemistry COVID-19 SARS-CoV-2 DPP4 receptor binding domain molecular interactions ADENOSINE-DEAMINASE PREDICTION ACE2 has been established as the main receptor for SARS-CoV-2. Since other human coronaviruses are known to use co-receptors for viral cell entry, it has been suggested that DPP4 (CD26) could be a potential additional binding target or co-receptor, supported by early molecular docking simulation studies. However, recent biophysical studies have shown this interaction to be very weak. We have conducted detailed molecular docking simulations to predict the potential binding interactions between the receptor binding domain (RBD) of the spike protein of SARS-CoV-2 and DPP4 and compare them with the interactions observed in the experimentally determined structure of the complex of MERS-CoV with DPP4. Whilst the overall binding mode of the RBD of SARS-CoV-2 to DPP4 is predicted to be similar to that observed in the MERS-CoV-DPP4 complex, including a number of equivalent interactions, important differences in the amino acid sequences of SARS-CoV-2 and MERS-CoV result in substantially weakened interactions with DPP4. This is shown to arise from differences in the predicted proximity, nature and secondary structure at the binding interface on the RBD of SARS-CoV-2. These findings do not support DPP4 being a significant receptor for SARS-CoV-2. 2021 Journal Article http://hdl.handle.net/20.500.11937/86472 10.3390/ijms22137001 English http://creativecommons.org/licenses/by/4.0/ MDPI fulltext
spellingShingle Science & Technology
Life Sciences & Biomedicine
Physical Sciences
Biochemistry & Molecular Biology
Chemistry, Multidisciplinary
Chemistry
COVID-19
SARS-CoV-2
DPP4
receptor binding domain
molecular interactions
ADENOSINE-DEAMINASE
PREDICTION
Cameron, Kirsten
Rozano, Lina
Falasca, Marco
Mancera, Ricardo
Does the sars-cov-2 spike protein receptor binding domain interact effectively with the dpp4 (Cd26) receptor? A molecular docking study
title Does the sars-cov-2 spike protein receptor binding domain interact effectively with the dpp4 (Cd26) receptor? A molecular docking study
title_full Does the sars-cov-2 spike protein receptor binding domain interact effectively with the dpp4 (Cd26) receptor? A molecular docking study
title_fullStr Does the sars-cov-2 spike protein receptor binding domain interact effectively with the dpp4 (Cd26) receptor? A molecular docking study
title_full_unstemmed Does the sars-cov-2 spike protein receptor binding domain interact effectively with the dpp4 (Cd26) receptor? A molecular docking study
title_short Does the sars-cov-2 spike protein receptor binding domain interact effectively with the dpp4 (Cd26) receptor? A molecular docking study
title_sort does the sars-cov-2 spike protein receptor binding domain interact effectively with the dpp4 (cd26) receptor? a molecular docking study
topic Science & Technology
Life Sciences & Biomedicine
Physical Sciences
Biochemistry & Molecular Biology
Chemistry, Multidisciplinary
Chemistry
COVID-19
SARS-CoV-2
DPP4
receptor binding domain
molecular interactions
ADENOSINE-DEAMINASE
PREDICTION
url http://hdl.handle.net/20.500.11937/86472